News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Revs Up For Testing Of Over-The-Counter Lipitor


3/3/2014 8:19:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Looking backward to improve its future, Pfizer will once again try to gain FDA approval to market its blockbuster drug, atorvastatin (Lipitor), over-the-counter (OTC). Peter Loftus reports in the Wall Street Journal that the company has started a clinical study to support the application for low-dose atorvastatin (10 mg). Over-the-counter statins have been unsuccessfully proposed in the past. Merck tried several times to gain approval for lovastatin (Mevacor).

Help employers find you! Check out all the jobs and post your resume.

Read at Market Watch
Read at Forbes
Read at Wall Street Journal

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES